MLSS Milestone Scientific

Milestone Scientific Inc. is a biomedical technology research and development company that patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone's proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections.
Company profile
Ticker
MLSS
Exchange
Website
CEO
Leonard A. Osser
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
MILESTONE SCIENTIFIC INC/NJ, U S OPPORTUNITY SEARCH INC
SEC CIK
Corporate docs
IRS number
133545623
MLSS stock data
()
News
The Daily Biotech Pulse: Pfizer-BioNTech Preps For BLA Filing, Sonoma Surges, BioXcel Readout, Ortho Clinical Lands Contract
1 Apr 21
Earnings Scheduled For April 1, 2021
1 Apr 21
Milestone Scientific Shares See Volume; Co Granted U.S. Patent Titled 'Device and method for identification of a target region'
30 Mar 21
USPTO Site Shows Milestone Scientific Patent For 'Disposable assembly for drug infusion with pressure sensing for identification of and injection into fluid-filled anatomic spaces'
16 Mar 21
Milestone Scientific To Present At Q1 Virtual Investor Summit Mar. 24
12 Mar 21
Press releases
Milestone Scientific Provides 2020 Year-End Business Update; Reports a 78% Sequential Increase in Revenue for Q4 2020 Versus Q3 2020
1 Apr 21
Milestone Scientific Schedules 2020 Year-End Business Update Conference Call
30 Mar 21
Milestone Scientific to Present at the Q1 Virtual Investor Summit
12 Mar 21
Milestone Scientific Receives Notice of Allowance for European Patent Related to Combination of Nerve Stimulation and DPS Dynamic Pressure Sensing Technology® to Optimize Needle Tip Location in Ultrasound-Guided PNB Procedures
10 Mar 21
Milestone Scientific Inc. Commences Sales of CompuFlo® / CathCheck™ Disposables to the Nationally Recognized Medical University of South Carolina
2 Mar 21
Investment data
Securities sold
Number of investors
Calendar
31 Mar 21
13 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 14.22M | 14.22M | 14.22M | 14.22M | 14.22M | 14.22M |
Cash burn (monthly) | 75K | (positive/no burn) | 398.3K | 621.09K | 212.92K | 582.08K |
Cash used (since last report) | 257.62K | n/a | 1.37M | 2.13M | 731.41K | 2M |
Cash remaining | 13.97M | n/a | 12.86M | 12.09M | 13.49M | 12.22M |
Runway (months of cash) | 186.2 | n/a | 32.3 | 19.5 | 63.4 | 21.0 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Feb 21 | Leslie Bernhard | Common Stock, Par Value $0.001 | Sell | Dispose S | No | No | 3.61 | 20,000 | 72.2K | 45,000 |
16 Feb 21 | Leslie Bernhard | Common Stock, Par Value $0.001 | Sell | Dispose S | No | No | 3.87 | 25,000 | 96.75K | 65,000 |
11 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 3.85 | 10,000 | 38.5K | 9,921,039 |
8 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 3.37 | 600 | 2.02K | 9,931,039 |
8 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 3.36 | 2,216 | 7.45K | 9,931,639 |
8 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 3.35 | 7,184 | 24.07K | 9,933,855 |
4 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 3.2 | 7,780 | 24.9K | 9,941,039 |
3 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 3.1 | 15,000 | 46.5K | 9,948,819 |
3 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 2.99 | 14,000 | 41.86K | 9,963,819 |
3 Feb 21 | Giandomenico Trombetta | Common Stock | Sell | Dispose S | No | No | 3 | 1,000 | 3K | 9,978,819 |
Institutional ownership Q4 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
12.7% owned by funds/institutions
13F holders |
Current |
---|---|
Total holders | 45 |
Opened positions | 8 |
Closed positions | 7 |
Increased positions | 20 |
Reduced positions | 7 |
13F shares |
Current |
---|---|
Total value | 33.98M |
Total shares | 8.42M |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners |
Shares | Value |
---|---|---|
Vanguard | 2.55M | $5.4M |
BLK Blackrock | 2.11M | $4.47M |
Bridgeway Capital Management | 576.1K | $1.22M |
STT State Street | 542.23K | $1.15M |
NTRS Northern Trust | 476.59K | $1.01M |
Geode Capital Management | 472.27K | $1M |
swisspartners | 251.83K | $525K |
Nuveen Asset Management | 209.76K | $445K |
Charles Schwab Investment Management | 123.32K | $262K |
Mercer Global Advisors | 117.75K | $250K |
Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
add, addendum, Adriaan, ae, alliance, alter, analyzing, Anhui, Apr, Arjan, bad, Bank, Barcelona, Beijing, categorized, CathCheck, chain, Claudia, CompuPulse, CompuWave, constantly, covid, Creatd, Cresco, cybersecurity, demand, destroyed, dislodged, displaced, dissolved, diverting, economy, elevated, Elkem, enrollment, Etkon, Euroanaesthesia, evolve, evolving, exacerbate, expedient, FDIC, forgiven, globe, goal, heartbeat, hurdle, immigration, intelligence, intraperiod, IP, Jan, Jun, kit, large, led, length, Leyden, loan, LP, Maishida, manual, Mold, molding, mortgage, movement, noncash, Nordic, operatory, oversaw, Paycheck, perioperative, Pharmacy, pick, pool, PPP, pre, precautionary, Premier, prepayment, presence, prototype, pulsatile, rapidly, reached, reaching, recruit, relocation, remotely, reopening, resume, save, Savoy, short, showing, Simplifying, skilled, Spain, Straumann, Subtopic, suffice, surge, surviving, talent, therefrom, thousand, Ti, Title, unproven, USPTO, verification, verify, waveform, workforce, worsen, Xcentric
Removed:
accompany, accomplish, advertising, assured, Ave, bulk, button, CA, called, Canadian, capitalized, CCS, CFDA, circumference, collectability, Cornell, CT, cumulative, dba, delisted, domiciled, Edward, embodied, endeavored, exempt, exploring, feeling, feet, formed, fourth, Gale, infiltration, inform, initiate, initiative, Jerrick, Lavin, leasing, mailing, margin, methodology, modification, Ontario, opportunity, Orange, palatal, participation, PC, PDL, pension, perfecting, pilot, pledge, point, pressing, progressed, Proximate, release, replace, screen, secured, Seller, Sinopharm, slight, specialist, Specifically, supportable, targeting, touch, trained, unaffiliated, unaudited, unregistered, usage, vibration, Warren, Zelnick
Financial reports
10-K
2020 FY
Annual report
31 Mar 21
10-Q
2020 Q3
Quarterly report
15 Nov 20
10-Q
2020 Q2
Quarterly report
14 Aug 20
10-Q
2020 Q1
Quarterly report
14 May 20
10-K/A
2019 FY
Annual report (amended)
2 Apr 20
10-K
2019 FY
Annual report
30 Mar 20
10-Q
2019 Q3
Quarterly report
14 Nov 19
10-Q
2019 Q2
Quarterly report
13 Aug 19
10-Q
2019 Q1
Quarterly report
14 May 19
10-K
2018 FY
Annual report
1 Apr 19
Current reports
8-K
Departure of Directors or Certain Officers
7 Apr 21
8-K
Departure of Directors or Certain Officers
24 Mar 21
8-K
Entry into a Material Definitive Agreement
3 Mar 21
8-K
Submission of Matters to a Vote of Security Holders
11 Dec 20
8-K
Entry into a Material Definitive Agreement
30 Nov 20
8-K
Milestone Scientific Promotes Arjan Haverhals to President of Milestone Scientific
1 Sep 20
8-K
Milestone Scientific Announces Pricing of $14.0 Million Offering of Common Stock and Warrants
26 Jun 20
8-K
Milestone Scientific Regains Compliance with New York Stock Exchange Listing Standards
22 May 20
8-K
Departure of Directors or Certain Officers
5 May 20
8-K
Milestone Scientific Announces Pricing of Above Market $4.5 Million Offering of Common Stock and Warrants
9 Apr 20
Registration and prospectus
S-8
Registration of securities for employees
14 Jan 21
424B5
Prospectus supplement for primary offering
26 Jun 20
424B5
Prospectus supplement for primary offering
25 Jun 20
424B5
Prospectus supplement for primary offering
9 Apr 20
424B5
Prospectus supplement for primary offering
8 Apr 20
424B2
Prospectus for primary offering
20 May 19
S-3
Shelf registration
2 May 19
424B5
Prospectus supplement for primary offering
1 Feb 19
424B5
Prospectus supplement for primary offering
31 Jan 19
424B5
Prospectus supplement for primary offering
15 Dec 16
Proxies
PRE 14A
Preliminary proxy
9 Apr 21
DEF 14A
Definitive proxy
26 Oct 20
PRE 14A
Preliminary proxy
9 Oct 20
DEF 14A
Definitive proxy
5 Nov 19
PRE 14A
Preliminary proxy
4 Oct 19
DEF 14A
Definitive proxy
29 Apr 18
DEFA14A
Additional proxy soliciting materials
29 Apr 18
DEF 14A
Definitive proxy
11 Apr 17
DEF 14A
Definitive proxy
14 Apr 16
DEF 14A
Definitive proxy
29 Apr 15
Other
UPLOAD
Letter from SEC
15 Jun 20
CORRESP
Correspondence with SEC
9 Jun 20
UPLOAD
Letter from SEC
1 Jun 20
EFFECT
Notice of effectiveness
17 May 19
CORRESP
Correspondence with SEC
12 May 19
UPLOAD
Letter from SEC
8 May 19
EFFECT
Notice of effectiveness
3 May 16
CORRESP
Correspondence with SEC
1 May 16
CERTNYS
Certification of approval for NYSE listing
27 May 15
UPLOAD
Letter from SEC
20 Jan 11
Ownership
4
MILESTONE SCIENTIFIC / Joseph D'Agostino ownership change
7 Apr 21
4
MILESTONE SCIENTIFIC / Leslie Bernhard ownership change
18 Feb 21
4
MILESTONE SCIENTIFIC / Giandomenico Trombetta ownership change
12 Feb 21
4/A
MILESTONE SCIENTIFIC / LEONARD OSSER ownership change
10 Feb 21
4
MILESTONE SCIENTIFIC / Giandomenico Trombetta ownership change
8 Feb 21
4
MILESTONE SCIENTIFIC / Giandomenico Trombetta ownership change
5 Feb 21
4
MILESTONE SCIENTIFIC / Giandomenico Trombetta ownership change
3 Feb 21
4
MILESTONE SCIENTIFIC / Joseph D'Agostino ownership change
29 Jan 21
4
MILESTONE SCIENTIFIC / Giandomenico Trombetta ownership change
29 Jan 21
4
MILESTONE SCIENTIFIC / Joseph D'Agostino ownership change
13 Jan 21
Patents
GRANT
Utility
Device and method for identification of a target region
30 Mar 21
A method and apparatus are provided for use in locating a target region which is situated in the body of a subject, for example for the delivery of drugs.
APP
Utility
Device and Method for Identification of a Target Region
25 Mar 21
A method and apparatus are provided for use in locating a target region which is situated in the body of a subject, for example for the delivery of drugs.
GRANT
Utility
Disposable assembly for drug infusion with pressure sensing for identification of and injection into fluid-filled anatomic spaces
16 Mar 21
A disposable fluid flow assembly for operation in connection with a fluid pump configured to provide a flow of fluid to the disposable fluid flow assembly is provided.
GRANT
Utility
Apparatus for assisting a user in advancing a needle into a subject at a selected rate
23 Nov 20
A system (5, 405) for infusing medication into a subject is provided.
GRANT
Utility
Device and method for identification of a target region
11 May 20
A method and apparatus are provided for use in locating a target region which is situated in the body of a subject, for example for the delivery of drugs.
Transcripts
2020 Q4
Earnings call transcript
2 Apr 21
2020 Q3
Earnings call transcript
17 Nov 20
2020 Q2
Earnings call transcript
17 Aug 20
2020 Q1
Earnings call transcript
18 May 20
2019 Q3
Earnings call transcript
15 Nov 19
2019 Q2
Earnings call transcript
16 Aug 19
2019 Q1
Earnings call transcript
16 May 19
2018 Q4
Earnings call transcript
3 Apr 19
2018 Q3
Earnings call transcript
21 Nov 18
2018 Q2
Earnings call transcript
15 Aug 18
Reddit threads
Daily Discussion Thread - March 29th, 2021
29 Mar 21
Daily Discussion Thread - March 26th, 2021
26 Mar 21
Daily Plays - March 15, 2021
15 Mar 21
[DD] MLSS came across my scanner. This likely won't be a penny stock in April. Painless injections coming soon after patent granted.
11 Mar 21
Milestone Scientific, Inc. $MLSS
24 Feb 21
Daily General Discussion and spitballin thread
24 Feb 21
Daily Discussion Thread - November 17th, 2020
17 Nov 20
Daily Discussion Thread - November 16th, 2020
16 Nov 20